Nevoa
Nevoa is a privately held Arizona medical device company that sells the Nimbus whole-room fogging robot, the Stratus handheld fogger, and its proprietary EPA-registered Microburst hypochlorous acid solution to US hospitals, ambulatory surgical centers, and physician offices for automated surface disinfection and HAI reduction.
- Company typePrivate
- Founded2009
- HeadquartersScottsdale, United States
- Headcount11–50
- GTM typeB2B
- OfferingHardware or Manufacturing
What Nevoa does
Nevoa Inc. is a privately held medical device company founded in 2009 in Gilbert, Arizona, that develops automated surface disinfection systems for healthcare facilities. Its core product platform centers on two fogging devices, the Nimbus whole-room automated fogging robot and the Stratus handheld fogger, both of which dispense Microburst, a proprietary EPA-registered, pH-neutral hypochlorous acid (HOCl) solution that the company describes as 80 to 100 times more effective than bleach. The Nimbus system is patented and positioned as the only hospital-grade surface disinfection system approved for fogging with EPA-registered HOCl, delivering LOG 4-6 efficacy, 100% surface coverage (including shadowed areas that line-of-sight UV systems miss), and a 2-minute application plus 1-minute contact time that permits immediate room re-entry, unlike hydrogen peroxide vapor systems. Microburst features a patented mixing cap that eliminates shelf-life expiration and is bar-coded for quality control and tracking.
Nevoa sells to US acute-care hospitals, ambulatory surgical centers, and physician offices, addressing Healthcare Associated Infections (HAIs) that the company estimates affect 1.7 million patients and contribute to over 98,000 deaths annually at roughly $28 billion in direct hospital costs. The company operates a direct field-sales GTM with a consultative, demo-driven motion, supported by pilot programs, clinical case studies, content marketing, and the SterileAware podcast. Revenue mechanics combine capital equipment sales (Nimbus, Stratus) with a recurring Microburst consumable stream. Leadership includes CEO Martin McGonagle (formerly GE Healthcare, SC Johnson Professional), co-founder and COO Ernest Cunningham, VP of Sales Peter Hoff, and Clinical Director Connie Addessi (formerly Cardinal Health). Nevoa has raised approximately $16.4 million across four disclosed rounds from 2018 through January 2025.
Nevoa firmographics
Firmographics- Name
- Nevoa
- Legal name
- Nevoa Inc.
- Website
- https://nevoainc.com
- Company type
- Private
- Founded year
- 2009
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- Nevoa is a privately held Arizona medical device company that sells the Nimbus whole-room fogging robot, the Stratus handheld fogger, and its proprietary EPA-registered Microburst hypochlorous acid solution to US hospitals, ambulatory surgical centers, and physician offices for automated surface disinfection and HAI reduction.
- Ownership category
- akta.pro rank
Nevoa industry classification
Industry- Product category
- Healthcare Surface Disinfection Equipment
- NAICS
- Soap and Cleaning Compound Manufacturing (32561), Polish and Other Sanitation Good Manufacturing (325612), Industrial and Commercial Fan and Blower and Air Purification Equipment Manufacturing (333413), Soap, Cleaning Compound, and Toilet Preparation Manufacturing (3256)
- SIC
- Specialty Cleaning, Polishing And Sanitation Preparations (2842), Surgical & Medical Instruments & Apparatus (3841)
- akta.pro primary industry
- Disinfection & Surface Decontamination (Wipes, Sprays, Fogging, UV Robots) (HLAHANAD)
- akta.pro secondary industries
- Healthcare Facility & Medical Office Disinfection (HSAEAHAC), Electrostatic Spraying & Fogging Services (HSAEAHAD), Aerosol Disinfectants & Foggers (CRAJANAD)
Keywords
Where Nevoa is headquartered
LocationHeadquarters
- HQ city
- Scottsdale
- HQ country
- United States
- HQ region
- North America
Offices2 records
Markets served
Nevoa business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Operations, Supply Chain, Technology or R&D, Personnel, Marketing or Sales
Revenue model
- Fogging Equipment Sales: Sale of Nimbus and Stratus fogging devices to healthcare facilities for automated surface disinfection
- Consumables (Microburst Solution): Ongoing sales of proprietary Microburst HOCl disinfectant solution for use with fogging systems. Patented mixing cap ensures no shelf life expiration.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Other | Multi-year contract | Equipment and consumables with no upfront capital required mentioned as a pilot option |
Go-to-market motion1 record
Distribution channels1 record
Marketing channels6 records
Nevoa product offering
Product offeringCore offering
Nevoa designs, manufactures, and sells automated fogging disinfection hardware (Nimbus whole-room robot and Stratus handheld fogger) together with a proprietary EPA-registered hypochlorous acid (Microburst) consumable, sold primarily to U.S. healthcare facilities for automated environmental surface disinfection and Healthcare Associated Infection reduction. Revenue is anchored by equipment sales and ongoing consumable usage tied to those devices.
Product overview
Nevoa offers a unified portfolio of automated surface disinfection products for healthcare facilities, consisting of two fogging devices and a proprietary disinfectant solution. The flagship Nimbus is an automated whole-room fogging robot that provides comprehensive environmental surface disinfection using Microburst hypochlorous acid solution. The compact Stratus handheld fogger delivers the same advanced disinfection capability in a portable form factor for between-case applications in operating rooms and procedure areas. Both devices utilize Microburst, Nevoa's proprietary EPA-registered HOCl solution, which achieves 99.9999% microbial reduction on treated surfaces in just one minute. The portfolio is designed to automate and enhance healthcare facility disinfection protocols, reducing manual labor while improving consistency and efficacy.
Differentiator
Problem solved
Functional benefit
Products and services
- Nimbus Patented, automated whole-room fogging robot and surface disinfection system, the only one approved for fogging with EPA-registered hypochlorous acid (HOCl). Delivers LOG 4-6 efficacy, achieves 300x better disinfection than manual cleaning alone, uses 64% less labor for terminal cleaning, and enables immediate room re-entry after each cycle. Sold to hospitals, ambulatory surgical centers, and physician offices.
- Stratus Compact, lightweight (4.4 lbs) handheld fogger powered by Microburst HOCl solution for advanced surface disinfection between surgical cases. Features rechargeable battery and easy-fill reservoir, achieves comprehensive surface coverage in 2 minutes of application plus 1 minute of contact time, and kills 99.9999% of pathogens including Staph, MRSA, and Pseudomonas.
- Microburst Nevoa's proprietary EPA-registered, hospital-grade hypochlorous acid (HOCl) consumable that is 80x to 100x more effective than bleach. pH-neutral, non-toxic, environmentally safe, 100% biodegradable, with no shelf life due to its patented mixing cap and bar-coded for quality control and data tracking. Used as the recurring consumable with both Nimbus and Stratus fogging systems.
Quantifiable outcome
- 99.9999% microbial reduction on treated surfaces in 1 minute
- +5 more outcomes
Companies that use Nevoa
Customer profileSegments3 records
Ideal customer profiles3 records
Nevoa technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature4 records
Nevoa partnerships and signals
Strategic signalPartnerships
Two partnerships are on record, tiered core and minor.
- Two Arizona Hospitals (Validation Partners)coreTwo Arizona hospitals validated the Nimbus Disinfection Protocol efficacy for pathogen reduction. These hospital partnerships provided clinical validation of the disinfection system's effectiveness in real healthcare settings.
- Job OptionsminorNevoa partner profile featuring Job Options, a disability services organization. Details of the partnership arrangement are limited.
Scale indicators6 records
Recent moves6 records
Expansion highlights6 records
Nevoa competitors and assessment
Company assessmentBroad incumbents
- Ecolab Healthcare: Ecolab's healthcare division provides cleaning, sanitization, and disinfection products and services to hospitals globally, overlapping with Nevoa's infection-prevention and surface-disinfection proposition at a much larger scale.
- Bioquell (Ecolab): Bioquell's hydrogen peroxide vapor systems, now part of Ecolab, compete in the same hospital room bio-decontamination space as Nevoa and serve as a broad-incumbent reference point for the category.
- STERIS: STERIS is a large medical-device and sterilization company with infection-prevention products reaching the same hospital customers Nevoa sells into, providing both competition and an M&A comparable.
- GOJO Industries (Purell): GOJO, the maker of Purell, sells hand-hygiene and surface-disinfection products into hospitals and is a broad-incumbent supplier competing for infection-prevention budget at the same accounts.
- PDI Healthcare: PDI sells EPA-registered disinfectant wipes, sprays, and surface care products used in hospitals alongside (or instead of) automated systems like Nevoa's — a relevant incumbent in the same infection-prevention category.
- Clorox Healthcare: Clorox Healthcare is a major hospital-grade disinfectant brand (bleach and hydrogen peroxide wipes) used in the same EVS workflows that Nevoa targets, representing the manual-cleaning incumbents Nevoa aims to displace.
Direct peers
- Xenex Disinfection Services: Xenex makes LightStrike UV robots for hospital room disinfection — the most direct competitor to Nevoa's Nimbus in the automated healthcare-facility disinfection category, targeting the same EVS and infection-control buyers.
- Halosil International: Halosil produces HaloMist hydrogen peroxide-based disinfection systems and HaloFogger devices for healthcare and commercial facilities, making it a direct automated-fogging peer to Nevoa.
- Tru-D SmartUVC: Tru-D markets a UV disinfection robot used in hospital terminal cleaning, competing head-to-head with Nevoa's whole-room fogging approach for the same HAI-reduction budget.
- TOMI Environmental Solutions: TOMI's SteraMist ionized hydrogen peroxide system is another automated whole-room disinfection platform for hospitals and life-sciences facilities, closely comparable to Nimbus in delivery model and buyer.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat6 records
Key risks5 records
Key highlights6 records
Customer concentration
Nevoa social profiles
Digital presenceNevoa compliance and trust
Trust signalCompliance2 records
Nevoa financial estimates
Financial estimateRevenue estimate
Valuation estimate
Nevoa leadership team
Management profileNumber of profiles
Profiles4 records
Nevoa funding detail
Funding detailFunding overview
Funding rounds4 records
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Nevoa M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Nevoa
What does Nevoa do?
Nevoa designs, manufactures, and sells automated fogging disinfection hardware (Nimbus whole-room robot and Stratus handheld fogger) together with a proprietary EPA-registered hypochlorous acid (Microburst) consumable, sold primarily to U.S. healthcare facilities for automated environmental surface disinfection and Healthcare Associated Infection reduction. Revenue is anchored by equipment sales and ongoing consumable usage tied to those devices.
Is Nevoa a public or private company?
Nevoa is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was Nevoa founded?
Nevoa was founded in 2009. It employs 11 to 50 people.
Where is Nevoa based?
Nevoa is headquartered in Scottsdale, United States, in the North America region.
How does Nevoa make money?
Two revenue lines are on record. Fogging Equipment Sales are the primary driver. The others are consumables (Microburst Solution).
Who are Nevoa's main competitors?
Broad incumbents on record are Ecolab Healthcare, Bioquell (Ecolab), STERIS, GOJO Industries (Purell), PDI Healthcare and Clorox Healthcare. Direct peers are Xenex Disinfection Services, Halosil International, Tru-D SmartUVC and TOMI Environmental Solutions.
Does Nevoa have an API?
No public API is recorded for Nevoa.
What industry is Nevoa in?
Nevoa's product category is Healthcare Surface Disinfection Equipment. Its primary akta.pro industry code is HLAHANAD, Disinfection & Surface Decontamination (Wipes, Sprays, Fogging, UV Robots), with a secondary code of HSAEAHAC, Healthcare Facility & Medical Office Disinfection. Its NAICS code is 32561 and its SIC code is 2842.